Brain :: How appetite-stimulating brain cells work overtime during fasting

During periods of fasting, brain cells responsible for stimulating the appetite make sure that you stay hungry. Now, a new study of mice reported in the January issue of the journal Cell Metabolism, published by Cell Press, reveals the complex series of molecular events that keep those neurons active.

Exercise :: Pet owners more unhealthy than others

Health of working aged Finns pet owners tend to be more unhealthy and overweight (with more body mass index BMI) than others, revealed in a research from the University of Turku, Finland. Perceived health of pet owners was weak more often than that of those not having a pet.

Pregnancy :: Prenatal multivitamins for undernourished women reduce risk of low birth weight

Undernourished women who take a vitamin and mineral supplement while pregnant may be less likely than women taking only iron and folic acid supplements to have babies weighing less than 2,500 grams, and their newborns may be less likely to have morbidity in the first seven days of life, according to a report in the January issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

Sleep :: Narcolepsy caused by environmental exposures

A comprehensive review published in the Jan. 1 issue of the journal Sleep finds that, as with other diseases characterized by selective cell loss, narcolepsy may be caused by environmental exposures before the age of onset in genetically susceptible individuals.

Cancer :: Body composition controls cancer risks

Scientists have long thought that limiting the calories a person consumes can prevent, or at least slow the progression of certain cancers. But research at UAB (University of Alabama at Birmingham) using mice suggests that body composition ? whether a person is lean or obese ? actually is key to reducing cancer risks.

Diabetes :: Japan’s Otsuka to develop saxagliptin for type 2 diabetes

Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. announced Otsuka has been granted exclusive rights in Japan to develop and commercialize the investigational compound saxagliptin, being studied for the treatment of Type 2 diabetes. Saxagliptin, discovered by Bristol-Myers Squibb, is a dipeptidyl peptidase-4 (DPP-4) inhibitor currently in Phase III development in the United States and Europe.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack